Glenn Sblendorio
Directeur Général chez IVERIC BIO, INC.
Fortune : 850 171 $ au 30/04/2024
Postes actifs de Glenn Sblendorio
Sociétés | Poste | Début | Fin |
---|---|---|---|
AMICUS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/06/2006 | - |
Independent Dir/Board Member | 01/06/2006 | - | |
IVERIC BIO, INC. | Directeur Général | 01/07/2017 | - |
Directeur/Membre du Conseil | 01/07/2013 | 11/07/2023 | |
Directeur des opérations | 01/04/2016 | 29/01/2017 | |
Directeur Financier/CFO | 01/04/2016 | 01/05/2017 | |
Independent Dir/Board Member | 01/07/2013 | 01/04/2016 | |
President | 30/01/2017 | 01/05/2021 | |
Treasurer | 01/04/2016 | 01/05/2017 | |
MINERALYS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 13/09/2023 | - |
Independent Dir/Board Member | 13/09/2023 | - |
Historique de carrière de Glenn Sblendorio
Anciens postes connus de Glenn Sblendorio
Sociétés | Poste | Début | Fin |
---|---|---|---|
INTERCEPT PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 17/02/2014 | 08/11/2023 |
Independent Dir/Board Member | 17/02/2014 | 08/11/2023 | |
THE MEDICINES COMPANY | Directeur/Membre du Conseil | 01/07/2000 | 01/03/2016 |
Directeur Financier/CFO | 03/03/2006 | 01/03/2016 | |
Independent Dir/Board Member | 01/07/2000 | 23/11/2011 | |
President | 19/04/2012 | 01/03/2016 | |
Treasurer | 23/07/2009 | 01/03/2016 | |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Directeur Financier/CFO | 01/02/2002 | 01/11/2005 |
Sony Interactive Entertainment LLC
Sony Interactive Entertainment LLC Packaged SoftwareTechnology Services Sony Interactive Entertainment LLC develops game software. The company was founded on April 1, 2016 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | 01/01/1992 | 01/01/1996 |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Directeur Financier/CFO | 01/03/1992 | 01/07/1993 |
Mpm Capital Advisors LLC | Directeur Général | - | - |
░░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - |
░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
Formation de Glenn Sblendorio
Fairleigh Dickinson University | Masters Business Admin |
Pace University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 15 |
Israël | 2 |
Opérationnelle
Director of Finance/CFO | 7 |
Director/Board Member | 5 |
Independent Dir/Board Member | 5 |
Sectorielle
Health Technology | 9 |
Consumer Services | 3 |
Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
AMICUS THERAPEUTICS, INC. | Health Technology |
AMGEN INC. | Health Technology |
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
MINERALYS THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 9 |
---|---|
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
NuLens Ltd.
NuLens Ltd. Electronic ComponentsElectronic Technology NuLens Ltd. is engaged in to researching, developing and marketing the novel accommodative Intraocular Lens ('IOL') technology. The Company is focused on exploiting the novel technologies in its patents and developing a real accommodative IOL ('RA-IOL') with the unparalleled capacity of providing over 10 Diopters of accommodative power to the cataract market and a legitimate candidate for the treatment of presbyopia, a vision disorder involving the inability of the eye to focus on near activities such as reading a newspaper or finding a number in a phone book. The company was founded by Joshua Ben-Nun in September 2002 and is headquartered in Herzliya Pituach, Israel. | Electronic Technology |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Health Services |
Millennium Venture Management LLC | |
Sony Interactive Entertainment LLC
Sony Interactive Entertainment LLC Packaged SoftwareTechnology Services Sony Interactive Entertainment LLC develops game software. The company was founded on April 1, 2016 and is headquartered in San Mateo, CA. | Technology Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
IVERIC bio, Inc.
IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
Mpm Capital Advisors LLC |
- Bourse
- Insiders
- Glenn Sblendorio
- Expérience